Publication Cover
MYOPAIN
A journal of myofascial pain and fibromyalgia
Volume 23, 2015 - Issue 3-4
137
Views
12
CrossRef citations to date
0
Altmetric
Review

Recent Advancements in Animal Models of Fibromyalgia

Pages 104-111 | Received 25 Jun 2015, Accepted 12 Dec 2016, Published online: 11 Jan 2017

References

  • Wood PB, Holman AJ, Jones KD: Novel pharmacotherapy for fibromyalgia. Expert Opin Investig Drugs 16: 829–841, 2007
  • Russell IJ: Fibromyalgia syndrome: New developments in pathophysiology and management. IntroductionCNS Spectr 13: 4–5, 2008
  • Fitzcharles MA, Yunus MB: The clinical concept of fibromyalgia as a changing paradigm in the past 20 years. Pain Res Treat 2012: 184835, 2012
  • Bennett RM: Clinical manifestations and diagnosis of fibromyalgia. Rheum Dis Clin North Am 35: 215–232, 2009
  • Clauw DJ: Fibromyalgia: an overview. Am J Med 122: S3–13, 2009
  • Clauw DJ: Fibromyalgia and related conditions. Mayo Clin Proc 90: 680–692, 2015
  • Sluka KA, Clauw DJ: Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience 338: 114–129, 2016
  • Jones GT, Atzeni F, Beasley M, Flüß E, Sarzi-Puttini P, Macfarlane GJ: The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol 67: 568–575, 2015
  • Hoffman DL, Dukes EM: The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract 62: 115–126, 2008
  • Ablin JN, Buskila D: Emerging therapies for fibromyalgia: an update. Expert Opin Emerg Drugs 15: 521–533, 2010
  • Choy E, Marshall D, Gabriel ZL, Mitchell SA, Gylee E, Dakin HA: A systematic review and mixed treatment comparison of the efficacy of pharmacological treatments for fibromyalgia. Semin Arthritis Rheum 41: 335–345, 2011
  • Häuser W, Walitt B, Fitzcharles MA, Sommer C: Review of pharmacological therapies in fibromyalgia syndrome. Arthritis Res Ther 16: 201, 2014
  • Skaer TL: Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden. Pharmacoeconomics 32: 457–466, 2014
  • Wolfe F, Walitt BT, Katz RS, Häuser W: Social security work disability and its predictors in patients with fibromyalgia. Arthritis Care Res (Hoboken) 66: 1354–1363, 2014
  • Nagakura Y: Challenges in drug discovery for overcoming ‘dysfunctional pain': an emerging category of chronic pain. Expert Opin Drug Discov 10: 1043–1045, 2015
  • Nagakura Y, Oe T, Aoki T, Matsuoka N: Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia. Pain 146: 26–33, 2009
  • Sluka KA, Kalra A, Moore SA: Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve 24: 37–46, 2001
  • Gregory NS, Gibson-Corley K, Frey-Law L, Sluka KA: Fatigue-enhanced hyperalgesia in response to muscle insult: induction and development occur in a sex-dependent manner. Pain 154: 2668–2676, 2013
  • Nishiyori M, Ueda H: Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia. Mol Pain 4: 52, 2008
  • Quintero L, Moreno M, Avila C, Arcaya J, Maixner W, Suarez-Roca H: Long-lasting delayed hyperalgesia after subchronic swim stress. Pharmacol Biochem Behav 67: 449–458, 2000
  • Nagakura Y, Ito H, Shimizu Y: Animal models of fibromyalgia. New Insights into Fibromyalgia. Edited by WS Wilke, INTECH, Rijeka, Croatia, 2012, pp. 41–58
  • DeSantana JM, da Cruz KM, Sluka KA: Animal models of fibromyalgia. Arthritis Res Ther 15: 222, 2013
  • Tanaka M, Nakamura F, Mizokawa S, Matsumura A, Nozaki S, Watanabe Y: Establishment and assessment of a rat model of fatigue. Neurosci Lett 352: 159–162, 2003
  • Yasui M, Yoshimura T, Takeuchi S, Tokizane K, Tsuda M, Inoue K, Kiyama H: A chronic fatigue syndrome model demonstrates mechanical allodynia and muscular hyperalgesia via spinal microglial activation. Glia 62: 1407–1417, 2014
  • Wu YY, Jiang YL, He XF, Zhao XY, Shao XM, Du JY, Fang JQ: Effects of electroacupuncture with dominant frequency at SP 6 and ST 36 based on meridian theory on pain-depression dyad in rats. Evid Based Complement Alternat Med 2015: 732845, 2015
  • Liu SB, Zhao R, Li XS, Guo HJ, Tian Z, Zhang N, Gao GD, Zhao MG: Attenuation of reserpine-induced pain/depression dyad by gentiopicroside through downregulation of GluN2B receptors in the amygdala of mice. Neuromolecular Med 16: 350–359, 2014
  • Liu YT, Shao YW, Yen CT, Shaw FZ: Acid-induced hyperalgesia and anxio-depressive comorbidity in rats. Physiol Behav 131: 105–110, 2014
  • Souza RR, França SL, Bessa MM, Takahashi RN: The usefulness of olfactory fear conditioning for the study of early emotional and cognitive impairment in reserpine model. Behav Processes 100: 67–73, 2013
  • Chen CN, Chang KC, Lin RF, Wang MH, Shih RL, Tseng HC, Soung HS, Tsai CC: Nitric oxide pathway activity modulation alters the protective effects of (-)Epigallocatechin-3-gallate on reserpine-induced impairment in rats. Behav Brain Res 305: 198–211, 2016
  • Girotti M, Donegan JJ, Morilak DA: Chronic intermittent cold stress sensitizes neuro-immune reactivity in the rat brain. Psychoneuroendocrinology 36: 1164–1174, 2011
  • Sída P, Koupilová M, Hynie S, Klenerová V: Effects of two types of restraint stress on the learned behaviour in rats. Acta Medica (Hradec Kralove) 46: 153–156, 2003
  • Frange C, Hirotsu C, Hachul H, Araujo P, Tufik S, Andersen ML: Fibromyalgia and sleep in animal models: A current overview and future directions. Curr Pain Headache Rep 18: 434, 2014
  • Choy EH: The role of sleep in pain and fibromyalgia. Nat Rev Rheumatol 11: 513–520, 2015
  • Leys LJ, Chu KL, Xu J, Pai M, Yang HS, Robb HM, Jarvis MF, et al: Disturbances in slow-wave sleep are induced by models of bilateral inflammation, neuropathic, and postoperative pain, but not osteoarthritic pain in rats. Pain 154: 1092–1102, 2013
  • Landis CA, Levine JD, Robinson CR: Decreased slow-wave and paradoxical sleep in a rat chronic pain model. Sleep 12: 167–177, 1989
  • Silva A, Andersen ML, Tufik S: Sleep pattern in an experimental model of osteoarthritis. Pain 140: 446–455, 2008
  • Pawlyk AC, Morrison AR, Ross RJ, Brennan FX: Stress-induced changes in sleep in rodents: models and mechanisms. Neurosci Biobehav Rev 32: 99–117, 2008
  • Zeitzer JM: Control of sleep and wakefulness in health and disease. Prog Mol Biol Transl Sci 119: 137–154, 2013
  • Monti JM: Disturbances of sleep and wakefulness associated with the use of antihypertensive agents. Life Sci 41: 1979–1988, 1987
  • Miranda A, Peles S, Rudolph C, Shaker R, Sengupta JN: Altered visceral sensation in response to somatic pain in the rat. Gastroenterology 126: 1082–1089, 2004
  • Moloney RD, O'Mahony SM, Dinan TG, Cryan JF: Stress-induced visceral pain: Toward animal models of irritable-bowel syndrome and associated comorbidities. Front Psychiatry 6: 15 2015
  • Mogil JS: Animal models of pain: progress and challenges. Nat Rev Neurosci 10: 283–294, 2009
  • de Souza AH, da Costa Lopes AM, Castro CJ, Jr, Pereira EM, Klein CP, da Silva CA, Jr, da Silva JF, et al: The effects of Phα1β, a spider toxin, calcium channel blocker, in a mouse fibromyalgia model. Toxicon 81: 37–42, 2014
  • Vieira LB, Kushmerick C, Hildebrand ME, Garcia E, Stea A, Cordeiro MN, Richardson M, et al: Inhibition of high voltage-activated calcium channels by spider toxin PnTx3-6. J Pharmacol Exp Ther 314: 1370–1377, 2005
  • Staud R: Peripheral pain mechanisms in chronic widespread pain. Best Pract Res Clin Rheumatol 25: 155–164, 2011
  • Fornasari D: Pain mechanisms in patients with chronic pain. Clin Drug Investig 32 (Suppl 1): 45–52, 2012
  • Kellenberger S, Schild L: Epithelial sodium channel/degenerin family of ion channels: a variety of functions for a shared structure. Physiol Rev 82: 735–767, 2002
  • Baron A, Lingueglia E: Pharmacology of acid-sensing ion channels – Physiological and therapeutical perspectives. Neuropharmacology 94: 19–35, 2015
  • Kellenberger S, Schild L: International Union of Basic and Clinical Pharmacology. XCI. structure, function, and pharmacology of acid-sensing ion channels and the epithelial Na+ channel. Pharmacol Rev 67: 1–35, 2015
  • Sluka KA, Price MP, Breese NM, Stucky CL, Wemmie JA, Welsh MJ: Chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1. Pain 106: 229–239, 2003
  • Taguchi T, Katanosaka K, Yasui M, Hayashi K, Yamashita M, Wakatsuki K, Kiyama H, et al: Peripheral and spinal mechanisms of nociception in a rat reserpine-induced pain model. Pain 156: 415–427, 2015
  • Nagakura Y, Takahashi M, Noto T, Sekizawa T, Oe T, Yoshimi E, Tamaki K, Shimizu Y: Different pathophysiology underlying animal models of fibromyalgia and neuropathic pain: comparison of reserpine-induced myalgia and chronic constriction injury rats. Behav Brain Res 226: 242–249, 2012
  • Sugimura N, Ikeuchi M, Izumi M, Kawano T, Aso K, Kato T, Ushida T, et al: Repeated intra-articular injections of acidic saline produce long-lasting joint pain and widespread hyperalgesia. Eur J Pain 19: 629–638, 2015
  • Chen WN, Lee CH, Lin SH, Wong CW, Sun WH, Wood JN, Chen CC: Roles of ASIC3, TRPV1, and NaV1.8 in the transition from acute to chronic pain in a mouse model of fibromyalgia. Mol Pain 10: 40, 2014
  • Gregory NS, Brito RG, Fusaro MC, Sluka KA: ASIC3 is required for development of fatigue-induced hyperalgesia. Mol Neurobiol 53: 1020–1030, 2016
  • Montserrat-de la Paz S, García-Giménez MD, Ángel-Martín M, Fernández-Arche A: Validation and additional support for an experimental animal model of fibromyalgia. Mod Rheumatol 25: 116–122, 2015
  • Le Goff P: Is fibromyalgia a muscle disorder?. Joint Bone Spine 73: 239–242, 2006
  • Bonaterra GA, Then H, Oezel L, Schwarzbach H, Ocker M, Thieme K, Di Fazio P, Kinscherf R: Morphological alterations in gastrocnemius and soleus muscles in male and female mice in a fibromyalgia model. PLoS One 11: e0151116, 2016
  • Vallejo R, Tilley DM, Vogel L, Benyamin R: The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Pract 10: 167–184, 2010
  • Sagar DR, Burston JJ, Hathway GJ, Woodhams SG, Pearson RG, Bennett AJ, Kendall DA, et al: The contribution of spinal glial cells to chronic pain behaviour in the monosodium iodoacetate model of osteoarthritic pain. Mol Pain 7: 88, 2011
  • Schomberg D, Olson JK: Immune responses of microglia in the spinal cord: contribution to pain states. Exp Neurol 234: 262–270, 2012
  • Guevara C, Fernandez AC, Cardenas R, Suarez-Roca H: Reduction of spinal PGE2 concentrations prevents swim stress-induced thermal hyperalgesia. Neurosci Lett 591: 110–114, 2015
  • Jaggi AS, Singh N: Role of different brain areas in peripheral nerve injury-induced neuropathic pain. Brain Res 1381: 187–201, 2011
  • Zhuo M: Cortical plasticity as a new endpoint measurement for chronic pain. Mol Pain 7: 54, 2011
  • Napadow V, Harris RE: What has functional connectivity and chemical neuroimaging in fibromyalgia taught us about the mechanisms and management of ‘centralized' pain? Arthritis Res Ther 16: 425, 2014
  • Arora V, Chopra K: Possible involvement of oxido-nitrosative stress induced neuro-inflammatory cascade and monoaminergic pathway: underpinning the correlation between nociceptive and depressive behaviour in a rodent model. J Affect Disord 151: 1041–1052, 2013
  • Peres KC, Rodrigues CM, Binda N, Montijo DD, Gomez MV, Souto AA, de Souza AH: Coadministration of resveratrol and rice oil mitigates nociception and oxidative state in a mouse fibromyalgia-like model. Pain Res Treat 2016: 3191638, 2016
  • Klein CP, Sperotto ND, Maciel IS, Leite CE, Souza AH, Campos MM: Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice. Neuropharmacology 86: 57–66, 2014
  • Imbe H, Kimura A, Donishi T, Kaneoke Y: Repeated forced swim stress enhances CFA-evoked thermal hyperalgesia and affects the expressions of pCREB and c-Fos in the insular cortex. Neuroscience 259: 1–11, 2014
  • Blasco-Serra A, Escrihuela-Vidal F, González-Soler EM, Martínez-Expósito F, Blasco-Ausina MC, Martínez-Bellver S, Cervera-Ferri A, et al: Depressive-like symptoms in a reserpine-induced model of fibromyalgia in rats. Physiol Behav 151: 456–462, 2015

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.